Institutional Ownership Kal Vista Pharmaceuticals, Inc. (KALV)
This table provides information about the institutional ownership of Kal Vista Pharmaceuticals, Inc. (KALV). We have compiled data on the 131 institutions that hold shares in the stock, with a total of 53.3 Million shares, which have been reported (via 13F filing form) to have a value of $519 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vr Adviser, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
6,249,731
shares
|
$66.5 Million
8.73% of portfolio
|
Q1 2024
Added 52.7%
|
|
Suvretta Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
4,913,012
shares
|
$52.3 Million
1.73% of portfolio
|
Q4 2024
Added 16.64%
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
4,893,847
shares
|
$52.1 Million
3.11% of portfolio
|
Q4 2024
Added 13.24%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
4,887,867
shares
|
$52 Million
2.48% of portfolio
|
Q4 2024
Added 32.54%
|
|
Vestal Point Capital, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
4,770,000
shares
|
$50.8 Million
2.4% of portfolio
|
Q4 2024
Added 19.25%
|
|
Capital World Investors
Los Angeles, CA |
Feb 13, 2025 Q4 2024 |
3,374,064
shares
|
$35.9 Million
0.0% of portfolio
|
Q3 2024
Added 4.54%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,945,116
shares
|
$31.3 Million
0.0% of portfolio
|
Q2 2024
Added 21.09%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,255,243
shares
|
$24 Million
0.0% of portfolio
|
Q4 2024
Added 4.87%
|
|
Great Point Partners LLC
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,787,003
shares
|
$19 Million
9.98% of portfolio
|
Q4 2024
Added 37.51%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,390,863
shares
|
$14.8 Million
0.0% of portfolio
|
Q4 2024
Added 9.38%
|
|
Octagon Capital Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,370,000
shares
|
$14.6 Million
2.59% of portfolio
|
Q4 2024
New holding
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
1,288,401
shares
|
$13.7 Million
0.08% of portfolio
|
Q4 2024
Added 111.82%
|
|
Stem Point Capital LP
New York, NY |
Feb 14, 2025 Q4 2024 |
992,803
shares
|
$10.6 Million
2.1% of portfolio
|
Q4 2024
New holding
|
|
Emerald Advisers, LLC
|
Feb 11, 2025 Q4 2024 |
836,050
shares
|
$8.9 Million
0.3% of portfolio
|
Q4 2024
Added 0.01%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
822,352
shares
|
$8.75 Million
0.0% of portfolio
|
Q4 2024
Reduced 1.04%
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
811,678
shares
|
$8.64 Million
1.87% of portfolio
|
Q4 2024
Added 12.16%
|
|
Schroder Investment Management Group
London, X0 |
Feb 12, 2025 Q4 2024 |
805,445
shares
|
$8.57 Million
0.01% of portfolio
|
Q4 2024
Added 86.78%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
696,037
shares
|
$7.41 Million
0.0% of portfolio
|
Q4 2024
Added 14.66%
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
612,173
shares
|
$6.51 Million
1.25% of portfolio
|
Q4 2024
Added 6.55%
|
|
Saturn V Capital Management LLC
Austin, TX |
Feb 14, 2025 Q4 2024 |
556,489
shares
|
$5.92 Million
1.85% of portfolio
|
Q3 2024
Reduced 50.69%
|
|
Emerald Mutual Fund Advisers Trust
|
Feb 14, 2025 Q4 2024 |
549,688
shares
|
$5.85 Million
0.32% of portfolio
|
Q4 2024
Reduced 15.56%
|
|
Allostery Investments LP
Stamford, CT |
Feb 14, 2025 Q4 2024 |
479,100
shares
|
$5.1 Million
4.24% of portfolio
|
Q4 2024
New holding
|
|
Jefferies Financial Group Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
375,000
shares
|
$3.99 Million
0.02% of portfolio
|
Q3 2024
Added 114.29%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
374,631
shares
|
$3.99 Million
0.0% of portfolio
|
Q4 2024
Added 762.63%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
366,170
shares
|
$3.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.48%
|